2025-09-15T15:22:33-05:00 2024-12-31 135565207 KPMG LLP 345 PARK AVENUE NEW YORK NY 101540102 990PF 2024-01-01 820656623 THE SILVERSTEIN FOUNDATION FOR PARKINSON'S WITH GBA SILV 9175198108 PO BOX 237137 NEW YORK NY 10023 NATALIE SILVERSTEIN VICE PRES/TREASURER 9175198108 2025-09-15 1 0 DEVIN L DUNCAN P01249521 2127589700 2025-09-15 2024 2025-03-06 01:10:19Z X 240557 X 1500 X 10927 10927 13624 73647 39263 26051 50190 0 0 0 0 0 3694 0 0 3694 7000 0 0 7000 1092 0 0 1092 848 0 0 0 13173 2 0 13171 25807 2 0 24957 75000 75000 100807 2 0 99957 -74756 50188 0 255290 240557 240557 65434 0 0 320724 240557 240557 18915 18915 18915 18915 X 301809 221642 301809 221642 320724 240557 301809 -74756 0 227053 5411 221642 AUTOMATIC DATA PROCESSING INC D 2024-12-19 20574 5459 15115 15115 GILEAD SCIENCES INC D 2024-12-19 14817 118 14699 14699 ISHARES CORE MSCI EMERGING MARKETS ETF D 2015-09-11 2024-12-19 38256 28807 9449 9449 39263 698 0 698 0 698 249 0 0 0 249 0 449 0 0 0 0 0 0 0 0 0 0 1 1 NY 1 0 0 0 0 1 WWW.SILVERSTEINFOUNDATION.ORG JONATHAN T SILVERSTEIN 9175198108 PO BOX 237137 NEW YORK NY 10023 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 JONATHAN SILVERSTEIN PO BOX 237137 NEW YORK NY 10023 PRESIDENT / CHAIR OF BOARD 40.00 0 0 0 NATALIE SILVERSTEIN PO BOX 237137 NEW YORK NY 10023 VICE PRESIDENT / SECRETARY 20.00 0 0 0 GEOFFREY LEVIN PO BOX 237137 NEW YORK NY 10023 BOARD MEMBER 1.00 0 0 0 NONE 0 NONE 0 0 62629 190262 0 252891 0 0 252891 3793 249098 12455 12455 698 698 11757 0 11757 0 11757 99957 0 99957 11757 0 0 1761478 1761478 99957 0 0 0 11757 88200 0 0 1849678 0 0 0 0 0 0 0 1849678 1761478 88200 JONATHAN SILVERSTEIN NATALIE SILVERSTEIN THE SILVERSTEIN FOUNDATION FOR PARK PO BOX 237137 NEW YORK NY 10023 9175198108 INFO@SILVERSTEINFOUNDATION.ORG THE FOUNDATION'S BOARD OF TRUSTEES AND SCIENTIFIC ADVISORY COMMITTEE ACCEPT GRANT APPLICATIONS FROM ORGANIZATIONS FOCUSED ON RAPIDLY CONVERTING SCIENTIFIC IDEAS AND EXPERIMENTAL DRUGS INTO FDA APPROVED THERAPEUTICS TO TREAT AND PREVENT THE ONSET OF PARKINSON'S DISEASE IN GBA-MUTATION CARRIERS. THE FOUNDATION REVIEWS QUALIFIED GRANT APPLICATIONS AS RECEIVED. NONE BAYLOR COLLEGE OF MEDICINE 1 BAYLOR PLAZA SUITE 409H HOUSTON TX 77030 HUSTON TX 77030 N/A PC THE SILVERSTEIN FELLOWSHIP. 75000 75000 0 14 10927 18 13624 0 24551 0 24551 0 0 0 0 0 0 0 0 0 0 ACCOUNTING FEES 7000 0 0 7000 TEL AVIV SOURASKY MEDICAL CENTER WEIZMANN ST 6 TEL AVIVYAFO IS 6423906 2023-02-27 276000 PROJECT: THE ROLE OF THE IMMUNE SYSTEM IN GLUOCEREBROSIDASE (GBA)-PD: A CSF AND PBMC STUDY 276000 NO 11/1/2024 2025-09-15 FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) SUNNYBROOK RESEARCH INSTITUTE 2075 BAYVIEW AVENUE TORONTO ONTARIO CA M4N 3M5 2023-02-22 250000 PROJECT: A PHASE I/II STUDY FOR BILATERAL PUTAMENAL DELIVERY OF RECOMBINANT GLUCOCEREBROSIDASE IN PATIENTS WITH PARKINSONS DISEASE USING MR-GUIDED FOCUSED ULTRASOUND INDUCED OPENING OF THE BLOOD-BRAIN BARRIER 250000 NO 2/22/2024 2025-09-15 FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) HAMAD BIN KHALIFA UNIVERSITY EDUCATION CITY - GATE 8 ARRAYYAN QA 00000 2023-08-29 190000 PROJECT: THERAPEUTIC NANOBODY DEVELOPMENT FOR TARGETING ALPHA-SYNUCLEIN AGGREGATION IN PARKINSON'S DISEASE, WITH FOCUS ON PARKINSON'S DISEASE WITH GBA MUTATION 190000 NO 10/1/2024 2025-09-15 FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) CURASEN THERAPEUTICS INC 930 BRITTAN AVENUE SUITE 306 SAN CARLOS CA 94070 2023-01-03 225000 PROJECT: GENOTYPING AND BIOMARKER ANALYSES IN CLINICAL STUDY 225000 NO 2/26/2024 2025-09-15 FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) LEGAL FEES 3694 0 0 3694 UNREALIZED (GAIN) / LOSS 5411 SOFTWARE LICENSE AND SUPPORT 3171 0 0 3171 OTHER EXPENSE 10002 2 0 10000 OTHER PROFESSIONAL FEES 1092 0 0 1092 TAXES UNDER SECTION 4940 848 0 0 0